A human monoclonal 1 antibody blocking SARS-CoV-2 infection
This is the paper submitted for review <a href="https://www.biorxiv.org/content/10.1101/2020.03.11.987958v1" rel="nofollow">https://www.biorxiv.org/content/10.1101/2020.03.11.987958v1</a><p>If it passesthe review stage it will probably be published in the scientific Journal Nature.<p>Note: this is not a vaccine. Its a treatment option for people who are already sick.